Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2012
02/15/2012CN101904953B 一种抗炎镇痛药物组合物及其制备方法和用途 An anti-inflammatory analgesic composition and preparation method and uses
02/15/2012CN101843667B 一种双黄连药物组合物及其制备方法 One kind Shuanghuanglian pharmaceutical composition and its preparation method
02/15/2012CN101824061B 一种来自中药黄芩的黄芩苷离子对药物和制备方法及其用途 One from the medicine skullcap baicalin ions on the preparation and use of drugs and
02/15/2012CN101693076B 金莲清热颗粒中牡荆苷的含量测定方法 Jinlianqingre particle method for the determination of vitexin
02/15/2012CN101691580B 人HMGB1 A box和酸性尾端的新型融合蛋白及其应用 Novel fusion protein of human HMGB1 A box and its applications and acidic tail end
02/15/2012CN101636414B 聚乙二醇修饰的干扰素α2b及其制备方法和应用 Pegylated interferon α2b and its preparation method and application
02/15/2012CN101440343B 苦瓜保健酒及其配制方法 Bitter health wine and its preparation method
02/15/2012CN101416961B 一种苯丙酸类药物光学异构体及其制药用途 One kind of styrene-acrylic acid drugs optical isomers and their pharmaceutical use
02/15/2012CN101380121B 一种金竹炖鸭的制备方法 One kind of bamboo stewed duck preparation
02/15/2012CN101327295B 一种毒排炎消的中药 One kind of poisonous exhaust Yan Xiao medicine
02/15/2012CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic
02/15/2012CN101022795B L-色氨酸与卡比多巴/苄丝肼的制剂 L- tryptophan and carbidopa / benserazide preparations
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114873 1,4-disubstituted naphthalenes as inhibitors of p38 map kinase
02/14/2012US8114840 Medicament containing activated antithrombin III
02/14/2012US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
02/14/2012US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response
02/14/2012US8114442 Transdermal pharmaceutical delivery compositions
02/14/2012US8114441 Immune stimulatory infant nutrition
02/14/2012US8114434 Diclofenac sodium patches for topical treatment of pain
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/09/2012WO2012019178A2 Methods of treating and diagnosing acute chest syndrome
02/09/2012WO2012018980A2 Compositions and methods for treating inflammatory diseases
02/09/2012WO2012018790A2 Dual variable domain immunoglobulins and uses thereof
02/09/2012WO2012018594A2 Plant-derived polysaccharides for delivery of rna-based therapies
02/09/2012WO2012018499A2 Specific regulation of cytokine levels by hdac6 inhibitors
02/09/2012WO2012018380A2 Compositions and methods for inducing immune tolerance
02/09/2012WO2012018377A2 Liposome targeting compounds and related uses
02/09/2012WO2012017700A1 Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator
02/09/2012WO2012017555A1 Elastase inhibitor
02/09/2012WO2012017551A1 Therapeutic agent for disease
02/09/2012WO2012017451A1 A bio-stabilized resveratrol formulation
02/09/2012WO2012017166A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/09/2012WO2012017027A1 Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof as bradykinin b1 receptor antagonists
02/09/2012WO2012016980A2 Use of sigma ligands in opioid-induced hyperalgesia
02/09/2012US20120036599 Novel fungal enzymes
02/09/2012US20120035557 Personal Care Compositions Comprising A Multi-Active System For Down Regulating Cytokines Irritation
02/09/2012US20120035268 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
02/09/2012US20120035265 Compositions, methods, and devices for the treatment of dysmenorrhea
02/09/2012US20120035264 Use of methionine sulfoximine to treat acute liver failure and other diseases caused by an inflammatory cytokine response
02/09/2012US20120035253 Crystalline forms of genistein
02/09/2012US20120035246 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
02/09/2012US20120035245 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
02/09/2012US20120035235 Methods of treating alpha adrenergic mediated conditions
02/09/2012US20120035226 Oxadiazole derivatives
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035216 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
02/09/2012US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use
02/09/2012US20120035199 Spiroheterocyclic compounds and their uses as therapeutic agents
02/09/2012US20120035194 Substituted 2-amino-fused heterocyclic compounds
02/09/2012US20120035178 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
02/09/2012US20120035177 Tablet formulation for p38 inhibitor and method
02/09/2012US20120035175 Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035162 Process for preparation of high-purity meloxicam and meloxicam potassium salt
02/09/2012US20120035161 Novel Compositions and Methods of Treating Diseases Using the Same
02/09/2012US20120035157 2-pyridone derivatives as neutrophil elastase inhibitors and their use
02/09/2012US20120035155 Indole-2-carboxamide deivative
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye
02/09/2012US20120035143 Drug combinations containing pde4 inhibitors and nsaids
02/09/2012US20120035140 Carbamoylphosphonates as inhibitors and uses thereof
02/09/2012US20120035132 Boron-containing small molecules
02/09/2012US20120035130 Chirally Correct Retinal Cyclodextrin Acetals for Clarifying Skin Complexion
02/09/2012US20120035127 Process for the production of a composition, the composition and the use thereof as food additive
02/09/2012US20120035107 Compositions for achieving a therapeutic effect in an anatomical structure
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034326 Novel herbal formulation advocated for the prevention and management of coronary heart disease
02/09/2012US20120034324 Role of an herbal formulation in the prevention and management of age related neurodegenerative disorders with special reference to senile dementia
02/09/2012US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
02/09/2012US20120034312 4-isopropyl-3-methylphenol for the treatment of inflammation
02/09/2012US20120034308 Reduced-cholesterol dairy product for use as a medicament
02/09/2012US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
02/09/2012US20120034298 Chewable Soft Capsule
02/09/2012US20120034292 Composition For Transdermal Delivery Of Fentanyl
02/09/2012US20120034278 Ophthalmic preparation containing menthyl ester of indomethacin
02/09/2012US20120034274 Pharmaceutical composition comprising one or more fumaric acid esters
02/09/2012US20120034270 S1P Receptors Modulators
02/09/2012US20120034245 Single-chain multivalent binding proteins with effector function
02/09/2012US20120034232 Tlr3 binding agents
02/09/2012US20120034231 Compositions and methods of use for therapeutic antibodies
02/09/2012US20120034226 Diagnostic method of skin inflammatory disease
02/09/2012US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof
02/09/2012US20120034216 Spiroketals
02/09/2012US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases
02/09/2012US20120034195 Placental stem cells derive from post-partum manmalian placenta, and uses and methods of treatment using said cells
02/09/2012US20120034193 Treatment of neurotrophic factor mediated disorders
02/09/2012US20120034184 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication
02/09/2012US20120034169 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
02/09/2012US20120034164 Truncated car peptides and methods and compositions using truncated car peptides
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012US20120034159 Antibodies that bind both bcma and taci
02/09/2012CA2807150A1 Corticosteroids for the treatment of joint pain
02/09/2012CA2807141A1 Compositions and methods for inducing immune tolerance
02/09/2012CA2807139A1 Liposome targeting compounds and related uses
02/09/2012CA2807078A1 Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof asbradykinin b1 receptor antagonists
02/09/2012CA2807069A1 Use of sigma ligands in opioid-induced hyperalgesia
02/09/2012CA2805206A1 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/08/2012EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors
1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 1272